Last reviewed · How we verify
Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ)
The purpose of this study is to examine the impact of ascorbic acid (vitamin c) and zinc gluconate in reducing duration of symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19). Patients above the age of 18 who present to the Cleveland Clinic outpatient testing and receive a positive test for COVID-19 will be invited to participate.
Details
| Lead sponsor | The Cleveland Clinic |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 214 |
| Start date | Wed Apr 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Feb 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- COVID
- Corona Virus Infection
Interventions
- Ascorbic Acid
- Zinc Gluconate
- Ascorbic Acid and Zinc Gluconate
- Standard of Care
Countries
United States